160 related articles for article (PubMed ID: 17310260)
81. SELECTing the best.
Klein EA
J Urol; 2007 Feb; 177(2):428-9. PubMed ID: 17222603
[No Abstract] [Full Text] [Related]
82. [Modifications produced in the prostate in rat by hormonotherapy].
GRINBERG R
Rev Soc Argent Biol; 1953; 29(1-2):21-8. PubMed ID: 13112789
[No Abstract] [Full Text] [Related]
83. Inhibition of growth of primary human prostate cells by phytoestrogens.
Hempstock J; Kavanagh JP; George NJ
J Med Food; 1999; 2(3-4):243-6. PubMed ID: 19281391
[No Abstract] [Full Text] [Related]
84. Chickpea Sprouts as a Potential Dietary Support in Different Prostate Disorders-A Preliminary In Vitro Study.
Galanty A; Prochownik E; Grudzińska M; Paśko P
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474555
[TBL] [Abstract][Full Text] [Related]
85. The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer.
Pejčić T; Zeković M; Bumbaširević U; Kalaba M; Vovk I; Bensa M; Popović L; Tešić Ž
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829927
[TBL] [Abstract][Full Text] [Related]
86. Effect of Ultraviolet C Irradiation on Isoflavone Concentrations in Different Cultivars of Soybean (
Karki KB; Mishra AK; Choi SJ; Baek KH
Plants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824390
[TBL] [Abstract][Full Text] [Related]
87. Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells.
Batra N; Sam A; Woldemariam T; Talbott G; de Vere White RW; Ghosh PM; Gaikwad NW; Kotchoni SO; Vinall RL
Biomedicines; 2020 Aug; 8(8):. PubMed ID: 32796613
[TBL] [Abstract][Full Text] [Related]
88. Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data.
Merriel SWD; May MT; Martin RM
BMJ Open; 2018 Jan; 8(1):e019409. PubMed ID: 29391368
[TBL] [Abstract][Full Text] [Related]
89. Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
Lecomte S; Demay F; Ferrière F; Pakdel F
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28657580
[TBL] [Abstract][Full Text] [Related]
90. Anti-cancer potential of flavonoids: recent trends and future perspectives.
Batra P; Sharma AK
3 Biotech; 2013 Dec; 3(6):439-459. PubMed ID: 28324424
[TBL] [Abstract][Full Text] [Related]
91. Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey.
Reger MK; Zollinger TW; Liu Z; Jones J; Zhang J
Eur J Nutr; 2016 Apr; 55(3):1029-40. PubMed ID: 25943648
[TBL] [Abstract][Full Text] [Related]
92. Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease.
Zhao L; Mao Z; Chen S; Schneider LS; Brinton RD
J Alzheimers Dis; 2013; 37(2):403-19. PubMed ID: 23948892
[TBL] [Abstract][Full Text] [Related]
93. The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.
Zuniga KE; Clinton SK; Erdman JW
Cancer Prev Res (Phila); 2013 Jun; 6(6):548-57. PubMed ID: 23592738
[TBL] [Abstract][Full Text] [Related]
94. Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments.
Yao J; Zhao L; Mao Z; Chen S; Wong KC; To J; Brinton RD
Brain Res; 2013 Jun; 1514():128-41. PubMed ID: 23428542
[TBL] [Abstract][Full Text] [Related]
95. Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause.
Zhao L; Mao Z; Schneider LS; Brinton RD
Menopause; 2011 Oct; 18(10):1131-42. PubMed ID: 21738079
[TBL] [Abstract][Full Text] [Related]
96. Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
Travis RC; Spencer EA; Allen NE; Appleby PN; Roddam AW; Overvad K; Johnsen NF; Olsen A; Kaaks R; Linseisen J; Boeing H; Nöthlings U; Bueno-de-Mesquita HB; Ros MM; Sacerdote C; Palli D; Tumino R; Berrino F; Trichopoulou A; Dilis V; Trichopoulos D; Chirlaque MD; Ardanaz E; Larranaga N; Gonzalez C; Suárez LR; Sánchez MJ; Bingham S; Khaw KT; Hallmans G; Stattin P; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
Br J Cancer; 2009 Jun; 100(11):1817-23. PubMed ID: 19436304
[TBL] [Abstract][Full Text] [Related]
97. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer.
Kenfield SA; Chang ST; Chan JM
Curr Treat Options Oncol; 2007 Jun; 8(3):173-96. PubMed ID: 17763836
[TBL] [Abstract][Full Text] [Related]
98. Effects of soy phytoestrogens on the prostate.
Goetzl MA; Van Veldhuizen PJ; Thrasher JB
Prostate Cancer Prostatic Dis; 2007; 10(3):216-23. PubMed ID: 17310260
[TBL] [Abstract][Full Text] [Related]
99. Soy, disease prevention, and prostate cancer.
Moyad MA
Semin Urol Oncol; 1999 May; 17(2):97-102. PubMed ID: 10332923
[TBL] [Abstract][Full Text] [Related]
100. Soy, isoflavones, and prostate cancer.
Jian L
Mol Nutr Food Res; 2009 Feb; 53(2):217-26. PubMed ID: 18985655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
